drugset
drugset / Trial / NCT05788497

Efficacy and Safety of Hemorrane Plus Versus Hemorrane and Versus Placebo in Patients With Uncomplicated Haemorrhoids

NCT05788497 ↗

Phase 3 Terminated 21 enrolled Faes Farma, S.A. Dynamic Science S.L. · collab
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This is a Multicentre, double-blind, randomised clinical trial to evaluate and compare the efficacy and safety of Hemorrane Plus (Hemorrane® + benzocaine) with Hemorrane® and with placebo in patients with uncomplicated haemorrhoids.

Timeline

Start
2023-03-30
Primary completion
2024-01-04
Completion
2024-01-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Benzocaine Small molecule 30 unknown Rectal
Subject Hemorrane Unknown 10 unknown Rectal

Indications

hemorrhoid